The weekly injection was approved by the US Food and Drug Administration in 2017 for people with type 2 diabetes.

Danish pharmaceutical company Novo Nordisk has finally launched its popular diabetes drug Ozempic in India, setting the price of the 0.25 mg starting dose at ₹ 2,200 per week.

As per the report, the company will sell the injectable drug in the country in 0.25 mg, 0.5 mg and 1 mg strengths.

Notably, Ozempic is an injectable drug for type 2 diabetes and has to be taken once a week.

The weekly injection was approved by the US Food and Drug Administration in 2017 for people with type 2 diabetes. Since then, it has become a global bestseller and is often used off-label for weight loss due to its appetite-reducing effects.

The lowest dose of the drug will be sold at a price

See Full Page